Michael Terrence Gibbs has not been actively trading shares of T2 Biosystems within the last three months. Most recently, Michael Terrence Gibbs sold 239 shares of the business's stock in a transaction on Tuesday, March 28th. The shares were sold at an average price of $0.48, for a transaction totalling $114.72. Following the completion of the sale, the general counsel now directly owns 6,612 shares of the company's stock, valued at $3,173.76. Learn More on Michael Terrence Gibbs' trading history.